Volpara Health Technologies (ASX:VHT): Chairman Roger Allen, CEO Ralph Highnam and Chief Commercial Officer Mark Koeniguer present at the 2016 AGM.This year was a very significant year for Volpara Health Technologies. Our listing back in April and raising $10 million was a significant milestone for the company.
We are also in the process of building a world-class sales and marketing team, with 6 additional US sales staff and VP of Sales for Europe and the Asia Pacific.
We halve also launched our cloud based VolparaEnterprise product with Software as a Service pricing.
Highlights:1. Building of a world-class sales & marketing team, we now have 6 additional US sales staff and VP Sales for Europe and Asia-Pacific.
2. Launching of Cloud-based, VolparaEnterprise product with Software as a Service pricing. Appeals to the whole breast imaging centre, not just the clinical team, and covering clinical, safety, quality and productivity, all based on our core, patented, technology.
3. Limited sales resources, increased product revenue FY15/16 by 31% • Increased customer sites to now be in 35 countries, with the latest being our first African site in Nigeria.
4. Strong platform for growth and bringing the benefits of our world class technology to women globally.
5. Board and Management have worked hard over the last year of significant achievement, and we re-iterate the commitment to grow the company and drive an increase in shareholder value.
